The plot simplifies!
If it is as simple as MT putting us up for sale to Amylx, then for the long termers wanting upside to benefit from future diseases, this could be a smart play.
As Amylx is now effectively a cashed-up shell, this could still basically be viewed as a reverse T/O.
The lower the market cap of any buyer, and the fewer other products they have which do not have as much upside as MPL, the better imo.
It would be a shame if PAA got taken out for only the value of MND (say a script only deal) and then the buying company (say with $100bn market cap) then goes on to develop the other diseases (say adding 20bn value) and the resulting gain only coming to 20% That would be a complete piss take.
So give me a battered and bruised Amylx please
The plot simplifies!If it is as simple as MT putting us up for...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.90M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.0¢ | 20.0¢ | $191.1K | 906.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1300 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 9563 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
21.0¢ |
Change
0.000 ( 6.67 %) |
||||
| Open | High | Low | Volume | ||
| 22.0¢ | 22.5¢ | 20.5¢ | 533029 | ||
| Last updated 15.54pm 03/05/2024 ? | |||||
| PAA (ASX) Chart |